Wall St. Journal: A Double Standard on Transplant Tests

Medicare won’t cover kidney monitoring that a private insurer considers to be ‘medically necessary.’

By: The Wall Street Journal Editorial Board

Government healthcare rationing tends to operate under the radar, but there’s a glaring double standard on display in the case of kidney transplant patients who want blood tests that can detect early signs of organ rejection. Medicare patients can’t get them, even as the tests are categorized as “medically necessary” by private insurance.

For the full article, visit the Wall St. Journal’s website